Today: 12 June 2026
Browse Category

NASDAQ:MGRX 13 November 2025 - 23 February 2026

Mangoceuticals stock slips before the bell after a 49% surge — what traders watch next for MGRX

Mangoceuticals stock slips before the bell after a 49% surge — what traders watch next for MGRX

Mangoceuticals shares fell about 4% to 51 cents in premarket trading Monday, easing after a 49% surge Friday that followed news of strong early sales for its $99-a-month testosterone therapy. Trading volume Friday spiked to 349 million shares. The company remains below Nasdaq’s $1 minimum bid requirement and has until August 3, 2026, to regain compliance.
23 February 2026
·
Mangoceuticals (MGRX) Soars on Eli Lilly and Novo Nordisk Deal as It Launches MangoRx Direct for Obesity Drugs

Mangoceuticals (MGRX) Soars on Eli Lilly and Novo Nordisk Deal as It Launches MangoRx Direct for Obesity Drugs

Mangoceuticals announced partnerships with Eli Lilly and Novo Nordisk to offer official access to Zepbound and Wegovy through new telehealth programs, MangoRx Direct and PeachesRx Direct. Membership costs $99 per month, with GLP‑1 drugs starting at $499 monthly, no insurance required. MGRX shares jumped over 25% pre-market before retreating. The company recently settled a lawsuit with Lilly and reported a $10.3 million net loss.
13 November 2025
····

Stock Market Today

  • Marvell Shares Dip Premarket After 11% Gain, S&P 500 Inclusion Set for June 22
    June 12, 2026, 8:42 AM EDT. Marvell Technology shares slipped 1.7% premarket Friday after surging 11.13% Thursday, reflecting investor caution despite its upcoming inclusion in the S&P 500 index on June 22. The semiconductor maker reported strong fiscal Q1 revenue growth of 28% to $2.418 billion and reaffirmed its fiscal Q2 outlook. Investor focus remains on Marvell's role in the AI data-center infrastructure market, highlighted by its new Teralynx T100 chip designed for AI clusters. The company appointed Dan Durn as CFO effective June 15, with former CFO Willem Meintjes remaining as adviser through April 2027. While enthusiasm persists around Marvell's AI-driven growth, concerns linger over its high valuation near a 96 price-to-earnings ratio and reliance on a limited customer base.

Latest articles

Richtech Robotics Stock Drops After Restatement Warning

Richtech Robotics Stock Drops After Restatement Warning

12 June 2026
Richtech Robotics plunged up to 10% premarket after disclosing that audited financial statements for 2024, 2025, and multiple quarters should not be relied upon, citing errors tied to warrant liabilities, a SEPA, and restricted stock awards; investors now await amended filings and Nasdaq compliance updates as valuation remains uncertain.
National Grid Shares Slip After UK Grid Reform; £70bn Plan in Spotlight

National Grid Shares Slip After UK Grid Reform; £70bn Plan in Spotlight

12 June 2026
National Grid shares slipped 0.41% to 1,203p, underperforming the FTSE 100, as investors weighed the impact of UK grid-connection reforms that boost long-term investment prospects but increase execution risk; next catalysts are the July AGM/dividend vote and November half-year results, with analysts’ median 12-month target at 1,388.5p, about 15% above current levels.
Go toTop